AAAAAA
Results: 1-25/33
Authors:
PELOQUIN CA
BERNING SE
HUITT GW
ISEMAN MD
Citation: Ca. Peloquin et al., LEVOFLOXACIN FOR DRUG-RESITANCE MYCOBACTERIUM-TUBERCULOSIS, The Annals of pharmacotherapy, 32(2), 1998, pp. 268-269
Authors:
PELOQUIN CA
BULPITT AE
JARESKO GS
JELLIFFE RW
JAMES GT
NIX DE
Citation: Ca. Peloquin et al., PHARMACOKINETICS OF PYRAZINAMIDE UNDER FASTING CONDITIONS, WITH FOOD,AND WITH ANTACIDS, Pharmacotherapy, 18(6), 1998, pp. 1205-1211
Authors:
PELOQUIN CA
Citation: Ca. Peloquin, RIFAMPIN STABILITY, Therapeutic drug monitoring, 20(4), 1998, pp. 450-451
Authors:
AMSDEN GW
CHENG KL
PELOQUIN CA
NAFZIGER AN
Citation: Gw. Amsden et al., ORAL CIMETIDINE PROLONGS CLARITHROMYCIN ABSORPTION, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1578-1580
Authors:
CHENG KL
NAFZIGER AN
PELOQUIN CA
AMSDEN GW
Citation: Kl. Cheng et al., EFFECT OF GRAPEFRUIT JUICE ON CLARITHROMYCIN PHARMACOKINETICS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 927-929
Authors:
PELOQUIN CA
Citation: Ca. Peloquin, SERUM CONCENTRATIONS OF THE ANTIMYCOBACTERIAL DRUGS, Chest, 113(5), 1998, pp. 1154-1155
Authors:
PELOQUIN CA
BERNING SE
Citation: Ca. Peloquin et Se. Berning, ADVICE ON TREATMENT OF DRUG-RESISTANT TUBERCULOSIS, American journal of health-system pharmacy, 54(6), 1997, pp. 700-701
Authors:
PELOQUIN CA
BERNING SE
Citation: Ca. Peloquin et Se. Berning, ADVICE ON TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX INFECTION, American journal of health-system pharmacy, 54(10), 1997, pp. 1208-1209
Authors:
HAFNER R
COHN JA
WRIGHT DJ
DUNLAP NE
EGORIN MJ
ENAMA ME
MUTH K
PELOQUIN CA
MOR N
HEIFETS LB
DUNLAP N
PHILLIPS P
CAMPO R
JAMES P
SENSION M
BOURIE M
WITT M
KRUGER S
MUSHATT D
GREENSPAN D
Citation: R. Hafner et al., EARLY BACTERICIDAL ACTIVITY OF ISONIAZID IN PULMONARY TUBERCULOSIS - OPTIMIZATION OF METHODOLOGY, American journal of respiratory and critical care medicine, 156(3), 1997, pp. 918-923
Authors:
PELOQUIN CA
Citation: Ca. Peloquin, MYCOBACTERIUM-AVIUM COMPLEX INFECTION - PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS THAT MAY IMPROVE CLINICAL OUTCOMES, Clinical pharmacokinetics, 32(2), 1997, pp. 132-144
Authors:
PELOQUIN CA
Citation: Ca. Peloquin, USING THERAPEUTIC DRUG-MONITORING TO DOSE THE ANTIMYCOBACTERIAL DRUGS, Clinics in chest medicine, 18(1), 1997, pp. 79
Authors:
PELOQUIN CA
JARESKO GS
YONG CL
KEUNG ACF
BULPITT AE
JELLIFFE RW
Citation: Ca. Peloquin et al., POPULATION PHARMACOKINETIC MODELING OF ISONIAZID, RIFAMPIN, AND PYRAZINAMIDE, Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2670-2679
Authors:
AMSDEN GW
PELOQUIN CA
BERNING SE
Citation: Gw. Amsden et al., THE ROLE OF ADVANCED GENERATION MACROLIDES IN THE PROPHYLAXIS AND TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX (MAC) INFECTIONS, Drugs, 54(1), 1997, pp. 69-80
Authors:
PELOQUIN CA
NITTA AT
BURMAN WJ
BRUDNEY KF
MIRANDAMASSARI JR
MCGUINNESS ME
BERNING SE
GERENA GT
Citation: Ca. Peloquin et al., LOW ANTITUBERCULOSIS DRUG CONCENTRATIONS IN PATIENTS WITH AIDS, The Annals of pharmacotherapy, 30(9), 1996, pp. 919-925
Authors:
PELOQUIN CA
Citation: Ca. Peloquin, QUINOLONES AND TUBERCULOSIS, The Annals of pharmacotherapy, 30(9), 1996, pp. 1034-1035
Authors:
BERNING SE
PELOQUIN CA
Citation: Se. Berning et Ca. Peloquin, ADVERSE EVENTS ASSOCIATED WITH HIGH-DOSE RIFABUTIN IN MACROLIDE-CONTAINING REGIMENS FOR THE TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX LUNG-DISEASE, Clinical infectious diseases, 22(5), 1996, pp. 885-885
Authors:
PELOQUIN CA
NITTA AT
BERNING SE
ISEMAN MD
JAMES GT
Citation: Ca. Peloquin et al., PHARMACOKINETIC EVALUATION OF THIACETAZONE, Pharmacotherapy, 16(5), 1996, pp. 735-741
Authors:
PELOQUIN CA
Citation: Ca. Peloquin, THERAPEUTIC DRUG-MONITORING OF THE ANTIMYCOBACTERIAL DRUGS, Clinics in laboratory medicine, 16(3), 1996, pp. 717
Authors:
BERNING SE
MADSEN L
ISEMAN MD
PELOQUIN CA
Citation: Se. Berning et al., LONG-TERM SAFETY OF OFLOXACIN AND CIPROFLOXACIN IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS, American journal of respiratory and critical care medicine, 151(6), 1995, pp. 2006-2009
Authors:
BRICELAND LL
CLEARY JD
FLETCHER CV
HEALY DP
PELOQUIN CA
Citation: Ll. Briceland et al., RECENT ADVANCES - ANTIINFECTIVES, The Annals of pharmacotherapy, 29(10), 1995, pp. 1035-1040
Authors:
STETTER MD
PELOQUIN CA
Citation: Md. Stetter et Ca. Peloquin, ISONIAZID AND RIFAMPIN SERUM LEVELS IN A COLOBUS MONKEY (COLOBUS-GUEREZA-CAUDATUS) INFECTED WITH MYCOBACTERIUM-BOVIS, Journal of zoo and wildlife medicine, 26(1), 1995, pp. 152-154
Authors:
ELLIOTT AM
BERNING SE
ISEMAN MD
PELOQUIN CA
Citation: Am. Elliott et al., FAILURE OF DRUG PENETRATION AND ACQUISITION OF DRUG-RESISTANCE IN CHRONIC TUBERCULOUS EMPYEMA, Tubercle and lung disease, 76(5), 1995, pp. 463-467
Authors:
FISH DN
BAINBRIDGE JL
PELOQUIN CA
Citation: Dn. Fish et al., VARIABLE DISPOSITION OF CIPROFLOXACIN IN CRITICALLY ILL PATIENTS UNDERGOING CONTINUOUS ARTERIOVENOUS HEMODIAFILTRATION, Pharmacotherapy, 15(2), 1995, pp. 236-245
Authors:
PELOQUIN CA
Citation: Ca. Peloquin, CLARIFICATION - CONTROVERSIES IN THE MANAGEMENT OF MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN AIDS, The Annals of pharmacotherapy, 28(6), 1994, pp. 808-808
Authors:
PELOQUIN CA
BERNING SE
Citation: Ca. Peloquin et Se. Berning, INFECTION CAUSED BY MYCOBACTERIUM-TUBERCULOSIS, The Annals of pharmacotherapy, 28(1), 1994, pp. 72-84